[ad_1]
The European Medicines Agency approved this Monday the first vaccine against the coronavirus, the one produced by Pfizer and BioNTech. The agency said new treatments will be approved early next year.
Representatives for the European Medicines Agency said Monday that they had interacted with other developers of other anti-COVID vaccines, but also with developers of potential treatments that are being developed.
Some could reach the European Medicines Agency early next year.
“As much as I am pleased to announce this news today (vaccine approval – no), I tell you that we are still at a tipping point in this pandemic. It will take time for us to vaccinate more people and ensure immunity. We know much more about this. disease now than 10 months ago, even more than we knew 3 months ago, but there is still new information that appears and needs to be evaluated, such as the new strain. “said a representative of the Agency.
Currently “there is no evidence” that the vaccine does not work against the new strain, said the representative of the European Agency.
In addition, he recommends that people do everything in their power to stop the spread of the virus, because the vaccine alone will not be the “miracle solution” to help us return to normal life, even if “it is a big step. “.
The first doses of vaccine will arrive in Romania on December 26 and will begin on December 27. vaccination of medical personnel of first-line hospitals.
Following Monday’s decision, EU countries will be able to launch national vaccination campaigns this week.
Also read: Nicolae Ciucă: We have everything we need to start the anti-COVID vaccination campaign on December 27
European Union countries, including Germany, Austria and Italy, have already announced plans to start vaccinations on December 27, as Europe tries to catch up with the United States and Great Britain, which already started their vaccination campaigns early on. December.
Publisher: DC
